General Information of the Compound
| Compound ID |
CP0376733
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-[[(2S)-4-carboxy-2-[[4-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]benzoyl]amino]butanoyl]-methylamino]pentanedioic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H33N5O9
|
||||||||||||||||||
| Molecular Weight |
619.631
|
||||||||||||||||||
| Canonical SMILES |
CN([C@@H](CCC(O)=O)C(O)=O)C(=O)[C@H](CCC(O)=O)NC(=O)c1ccc(cc1)N(CC#C)Cc1ccc2nc(C)[nH]c(=O)c2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H33N5O9/c1-4-15-36(17-19-5-10-23-22(16-19)29(42)33-18(2)32-23)21-8-6-20(7-9-21)28(41)34-24(11-13-26(37)38)30(43)35(3)25(31(44)45)12-14-27(39)40/h1,5-10,16,24-25H,11-15,17H2,2-3H3,(H,34,41)(H,37,38)(H,39,40)(H,44,45)(H,32,33,42)/t24-,25-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UEOHFABEMIXPIA-DQEYMECFSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound